Antiviral prophylaxis in haematological patients: systematic review and meta-analysis.

  title={Antiviral prophylaxis in haematological patients: systematic review and meta-analysis.},
  author={Dafna Yahav and Anat Gafter-Gvili and Eli Muchtar and Keren Skalsky and Galia Kariv and Moshe Yeshurun and Leonard Leibovici and Mical Paul},
  journal={European journal of cancer},
  volume={45 18},
PURPOSE Antiviral prophylaxis is commonly prescribed to haematological cancer patients. We conducted a systematic review and meta-analysis to quantify its overall benefit in specific clinical scenarios. METHODS Randomised controlled trials assessing antiviral prophylaxis versus placebo, no treatment, pre-emptive treatment or another antiviral drug were included. Patients undergoing haematopoietic stem cell transplantation (HSCT) or intensive chemotherapy for acute leukaemia or high-grade… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 15 extracted citations


Publications referenced by this paper.
Showing 1-10 of 116 references

Prevention of late CMV disease after HCT: a randomized double-blind multicenter trial of valganciclovir (VGCV) prophylaxis versus PCR-guided GCV/VGCV preemptive therapy

  • M Boeckh, G Nichols, R Chemaly
  • Biol Blood Marrow Transpl 2008;14:30
  • 2008

Aciclovir versus ganciclovir plus foscarnet for CMV prophylaxis in allogeneic haematopoietic stem cell transplantation

  • C Nozzoli, B Bartolozzi, S Guidi
  • 2007

Similar Papers

Loading similar papers…